The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse An exploratory, double-blind, randomized, placebo controlled, 2 period cross-over, pharmacokinetic/pharmacodynamic, single center study to asses the effect of AZD6140 on respiratory parameters in mild asthma and mild COPD patients age 55 to 75 years
- collapse An exploratory, double-blind, placebo controlled, 2 period cross-over, 3 cohort, single center, pharmacodynamic study to assess the effect of AZD6140 on respiratory parameters in healthy subjects, mild asthmatics and COPD patients age 40 to 70 years.
- collapse A Randomised, Double-Blind, 2-Period Crossover Study to Assess the Effect of Steady-State AZD6140 on the Pharmacokinetics of a Single Oral 500-mg Dose of Tolbutamide, a Substrate of CYP2C9, in Healthy Male and Female Volunteers.
- collapse COMPLIANCE An Observational Study of Treatment Compliance and Quality of Life in Patients on Antihypertensive Medication
- collapse Non-interventional study to assess reaching of cholesterol target values in patients treated with HMG-CoA reductase inhibitors in Bosnia and Herzegovina
- collapse Centralised Pan-Algerian Survey on the undertreatment of hypercholesterolemia
- collapse An observational study of statin treatment induced HDL changes - effect on cardiovascular disease
- collapse Observational study to understand patients’ and physicians’ attitudes to Statins in Turkey
- collapse A Double Masked, Placebo Controlled, Randomised, Parallel Group Phase IIa Study to assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-Ocular Pressure
- collapse Effectiveness of risk minimisation interventions for ticagrelor in Canada
